Patent SG-11201808069V-A (SG)
Title: System and process for neuroprotective therapy for glaucoma
Inventor: LUTTRULL JEFFREY K
IPC: A61F9/008
Filed: 2016-11-17
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 1111111111 011101010111110101111101110111110101110111111111011111011110111111 Organization International Bureau (10) International Publication Number (43) International Publication Date ......0\"\"1 WO 2017/192168 Al 09 November 2017 (09.11.2017) WIP0 I PCT (51) International Patent Classification: L.; 2879 MacArthur Blvd, Oakland, California 94602 (US). A61F 9/008 (2006.01) CHANG, David B.; 14212 Livingston, Tustin, California (21) International Application Number: 92780 (US). PCT/US2016/062421 (74) Agent: KELLEY, Scott W.; Kelly & Kelley, LLP, 6320 (22) International Filing Date: Canoga Avenue, Suite 1650, Woodland Hills, California 17 November 2016 (17.11.2016) 91367 (US). (25) Filing Language: English (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (26) Publication Language: English AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (30) Priority Data: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, 15/148,842 06 May 2016 (06.05.2016) US DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, 15/188,608 21 June 2016 (21.06.2016) US HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, 15/232,320 09 August 2016 (09.08.2016) US KZ, LA, MN, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, (71) Applicant: OJAI RETINAL TECHNOLOGY, LLC PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, [US/US]; 283 Carne Road, Ojai, California 93023 (US). SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (72) Inventors: LUTTRULL, Jeffrey K.; 283 Carne Road, Ojai, California 93023 (US). MARGOLIS, Benjamin W. Title: SYSTEM AND PROCESS FOR NEUROPROTECTWE THERAPY FOR GLAUCOMA = (54) = = 18 1 = ----- -- - -- -, = — = / I 7 i 11 12 = = 22 , 1 1 11 • , 14 16 = 20 I I v • \ r = = = \:\ _ = 114i %'41.. ..--....—.../ = 18 IIIIIIIIIIII/ FIG. 1 ,-1 . 4 GC 1-1 (57) : Providing neuroprotective therapy for glaucoma includes generating a micropulsed laser light beam having parameters ei and characteristics, including pulse length, power, and duty cycle, selected to create a therapeutic effect with no visible laser lesions or ON tissue damage to the retina. The laser light beam is applied to retinal and/or foveal tissue of an eye having glaucoma or a risk of glaucoma 1-1 --.... to create a therapeutic effect to the retinal and/or foveal tissue exposed to the laser light beam without destroying or permanently IN damaging the retinal and/or foveal tissue and improve function or condition of 1-1 an optic nerve and/or retinal ganglion cells of the eye. 0 ei O [Continued on next page] WO 2017/192168 Al MIDEDIM1111011111111111111111111111111111111111111111111111011110111110111111111111 (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3))